Quantitative analysis for Telix Pharmaceuticals Limited American Depositary Shares (TLX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Unrated (50.0). 30 signals analyzed (25 differentiated alt-data).
TLX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-05-06 | $11.15 | $10.90 | $11.11 |
| 2026-05-18 | $10.47 | $10.20 | $10.28 |
| 2026-05-29 | $9.53 | $9.40 | $9.43 |
| 2026-06-10 | $9.60 | $9.30 | $9.44 |
| 2026-06-23 | $10.30 | $10.03 | $10.21 |
| 2026-07-06 | $12.23 | $11.97 | $12.15 |
| 2026-07-16 | $11.05 | $10.79 | $10.83 |
| 2026-07-28 | $10.19 | $10.03 | $10.19 |
| 2026-08-07 | $11.58 | $11.44 | $11.52 |
| 2026-08-20 | $12.48 | $12.06 | $12.42 |
| 2026-09-01 | $10.96 | $10.80 | $10.85 |
| 2026-09-14 | $12.23 | $11.67 | $11.78 |
How Telix Pharmaceuticals Limited American Depositary Shares stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
Telix Pharmaceuticals Limited American Depositary Shares (TLX) scores Unrated (50.0), and the composite conceals a 81-point disagreement between its dimensions. It is strongest on technicals at 93, and weakest on analyst consensus at 12. A stock can carry technicals that high while analyst consensus sits at 12; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 93 |
| analyst consensus | 12 |
StoQuant analyzes 30 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Telix Pharmaceuticals Limited American Depositary Shares (TLX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/TLX"><img src="https://stoquant.com/badge/TLX.svg" alt="Telix Pharmaceuticals Limited American Depositary Shares (TLX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.